首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1542879

全球中央血管通路設備市場 - 2024-2031

Global Central Vascular Access Devices Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球中央血管接取設備市場規模達17.4億美元，預估至2031年將達28.2億美元，2024-2031年預測期間複合年成長率為6.2%。

中央血管通路裝置 (CVAD) 是專門的醫療工具，旨在實現靜脈治療、血液採樣以及其他基本醫療程序的執行。

中心靜脈接入裝置 (CVAD)，也稱為靜脈接入端口或導管，是放置在患者大靜脈中的薄、空心、軟性管，以允許頻繁接入血流中的線。這些裝置由外科醫生或介入性放射科醫生在使用或不使用全身麻醉的情況下插入。

CVAD 在當代醫療保健中至關重要，特別是對於接受化療、長期抗生素治療和全腸外營養等治療的個人而言。這些設備經過精心設計，可長時間保持在原位，非常適合需要經常接觸循環系統的患者。

市場動態：

司機

慢性病盛行率上升和技術進步

全球中央血管通路器械市場的需求受到多種因素的推動。主要因素之一是慢性病盛行率上升和技術進步。

心血管疾病（CVD）和慢性腎臟病（CKD）等慢性疾病的盛行率不斷上升，是推動中央血管通路裝置（CVAD）需求的主要因素。根據 NCBI 2023 年 11 月的研究出版物，慢性腎臟病 (CKD) 經常發生在糖尿病 (DM) 患者中，影響了約 40% 的患者。此外，DM 是心血管疾病 (CVD) 的重要危險因素，而 CKD 在調節這種風險方面發揮著至關重要的作用。

血管通路技術的進步，包括動力注射和抗菌導管的創建，正在提高這些設備的安全性和有效性。這些創新對於涉及高壓注射的程序（例如影像研究）尤其重要。

此外，該行業的主要參與者更加關注血管設備的研究以及將推動該市場成長的夥伴關係和協作。例如，2023 年 6 月，Magenta Medical 啟動了一項對其被認為是世界上最小的心臟幫浦的提升經皮左心室輔助裝置 (pLVAD) 的早期可行性研究。

本研究旨在評估該裝置在高風險經皮冠狀動脈介入治療 (HR-PCI) 手術期間最大限度地減少血管通路併發症的有效性。 Elevate 幫浦旨在提供臨時機械循環支持，在這些關鍵干預措施期間提高病人安全和結果。透過使用較小的插入輪廓，該設備旨在降低與通常需要更多侵入性手術的傳統較大幫浦相關的風險。

同樣，2023 年3 月，美國外科醫生學會(ACS) 和血管外科學會(SVS) 合作啟動了血管驗證計劃(Vascular-VP)，這是一項國家品質驗證計劃，旨在改善結果並為患者提供最佳護理在住院環境中接受血管外科和介入治療的患者。這項以證據為導向的標準化計劃為醫院建立和加強血管護理品質改善基礎設施提供了一個框架。

限制

感染和併發症的風險、CVAD 的放置和維護的高成本以及產品召回和故障等因素預計將阻礙市場。

細分市場分析

全球中央血管通路裝置市場根據類型、應用、最終用戶和地區進行細分。

給藥部分約佔全球中央血管通路器械市場佔有率的48.2%

預計藥物管理領域將在預測期內佔據最大的市場佔有率。包括慢性腎臟病（CKD）和癌症在內的慢性疾病的盛行率不斷上升，是推動藥物管理領域發展的關鍵因素。根據 ScienceDirect 2024 年 2 月發表的研究報告，全球約有 700-8 億人患有 CKD，推動了對中央血管通路器械市場的需求。

此細分市場的擴張主要是由於靜脈注射 (IV) 療法的需求不斷成長，這對於提供全身性治療至關重要，特別是對於慢性病患者。這些設備具有多種用途，包括給藥、血液提取和液體輸送，這使得它們成為臨床環境中的適應性工具。根據患者的具體要求，它們可以透過頸靜脈等中央插入，或在手臂外周插入。

此外，該行業的主要參與者推出了創新產品和技術開發，這將推動該細分市場在該市場的成長。例如，2023 年 10 月，B. Braun Medical Inc. 推出了具有多通道血液控制功能的新型 Introcan Safety 2 IV 導管。這項最新創新延續了貝朗對被動針刺預防的承諾。此導管不僅提供自動保護，防止針刺傷，還包括血液控制機制，可保護臨床醫生在每次訪問針座時避免血液暴露。這項功能顯著降低了靜脈注射 (IV) 過程中接觸血液傳染病原體的風險。

同樣，2023 年 12 月，貝朗推出了其創新的 CARESITE 微型魯爾接取裝置。該新產品旨在透過最大限度地減少有害化學物質的暴露並降低感染風險，提高患者和醫療保健專業人員靜脈注射 (IV) 通路的安全性。

市場地域佔有率

北美約佔全球中央血管通路器械市場佔有率的43.4%

由於慢性病盛行率不斷上升、技術進步、人口老化以及醫療設施的擴張推動了該地區的市場成長，預計北美地區將在預測期內佔據最大的市場佔有率。

此外，大量關鍵參與者的存在、先進的醫療保健基礎設施和產品發布將推動該市場的成長。例如，2023 年 11 月，BD 推出了 SiteRite 9 超音波系統，旨在提高臨床醫生放置各種血管通路裝置的效率，包括周邊插入中心靜脈導管 (PICC) 和中心靜脈導管。此先進系統具有方便用戶使用的 15.6 吋觸控螢幕和卓越的圖像質量，為成功放置導管提供了必要的工具。

此外，Shockwave Medical, Inc. 於 2022 年 3 月宣佈在獲得 CE 標誌和 FDA 批准後，在全球推出 Shockwave M5+ 周邊血管內碎石 (IVL) 導管。這種導管以前容量有限，經過專門設計，可以減少 IVL 手術的治療時間，提供替代的通路選擇，並將 IVL 治療擴展到血管尺寸較大的患者。 Shockwave M5+ 導管的推出代表了嚴重鈣化心血管疾病治療的重大進步，提高了血管介入治療的效率和效果。

此外，主要參與者的技術進步和產品批准推動了該市場的成長。例如，2023 年 11 月，BD 推出了新型 PIVOTM Pro 無針採血設備。這項創新解決方案已獲得 FDA 510(k) 許可，旨在與整合的長外周 IV 導管配合使用，包括 BD 的 Nexiva 封閉式 IV 導管系統（具有 NearPort IV 通道）。

Central venous access devices (CVAD), also referred to as venous access ports or catheters are thin, hollow, flexible tubes placed in large veins of patients to allow frequent access to threads in the bloodstream. These devices are inserted either by surgeons or interventional radiologists with or without the use of general anesthesia.

CVADs are essential in contemporary healthcare, especially for individuals receiving treatments like chemotherapy, prolonged antibiotic therapy, and total parenteral nutrition. These devices are engineered to stay in place for prolonged durations, making them well-suited for patients who need frequent access to their circulatory system.

Market Dynamics: Drivers

Rising prevalence of chronic diseases & technological advancements

The demand for the global central vascular access devices market is driven by multiple factors. One of the primary factors is the rising prevalence of chronic diseases & technological advancements.

The growing prevalence of chronic illnesses, including cardiovascular diseases (CVDs) and chronic kidney disease (CKD), is a major factor fueling the demand for central vascular access devices (CVADs). According to an NCBI research publication in November 2023, chronic kidney disease (CKD) frequently occurs in individuals with diabetes mellitus (DM), affecting about 40% of these patients. Additionally, DM serves as a significant risk factor for cardiovascular disease (CVD), with CKD playing a crucial role in mediating this risk.

Advancements in vascular access technology, including the creation of power-injectable and antimicrobial catheters, are improving the safety and effectiveness of these devices. These innovations are particularly important for procedures that involve high-pressure injections, like imaging studies.

Moreover, key players in the industry more focus on research studies in vascular devices and partnerships & collaborations that would drive this market growth. For instance, in June 2023, Magenta Medical initiated an early feasibility study for its Elevate Percutaneous Left Ventricular Assist Device (pLVAD), recognized as the world's smallest heart pump.

This study aims to assess the device's effectiveness in minimizing vascular access complications during high-risk percutaneous coronary intervention (HR-PCI) procedures. The Elevate pump is designed to provide temporary mechanical circulatory support, enhancing patient safety and outcomes during these critical interventions. By using a smaller insertion profile, the device seeks to reduce the risks associated with traditional larger pumps that typically require more invasive procedures.

Similarly, in March 2023, the American College of Surgeons (ACS) and the Society for Vascular Surgery (SVS) collaborated to launch the Vascular Verification Program (Vascular-VP), a national quality verification initiative aimed at improving outcomes and delivering optimal care for patients receiving vascular surgical and interventional treatment in inpatient settings. This evidence-driven, standardized program provides a framework for hospitals to establish and enhance their vascular care quality improvement infrastructure.

Restraints

Factors such as the risk of infections & complications, high costs involved in the placement and maintenance of CVADs, and product recalls and failures are expected to hamper the market.

Market Segment Analysis

The global central vascular access devices market is segmented based on type, application, end-user, and region.

The drug administration segment accounted for approximately 48.2% of the global central vascular access devices market share

The drug administration segment is expected to hold the largest market share over the forecast period. The growing prevalence of chronic illnesses, including chronic kidney disease (CKD) and cancer, is a key factor propelling the drug administration segment. As per ScienceDirect research publication in February 2024, around 700-800 million individuals worldwide suffer from CKD, driving the demand for central vascular access devices market.

The expansion of this segment is primarily fueled by the increasing need for intravenous (IV) therapies, which are crucial for delivering systemic treatments, particularly for patients with chronic illnesses. These devices serve multiple purposes, including drug administration, blood extraction, and fluid delivery, which makes them adaptable tools in clinical environments. They can be inserted centrally, for example, via the jugular vein, or peripherally in the arm, based on the specific requirements of the patient.

Moreover, key players in the industry have innovative product launches and technological developments that would drive this segment's growth in this market. For instance, in October 2023, B. Braun Medical Inc. unveiled its new Introcan Safety 2 IV Catheter featuring Multi-Access Blood Control. This latest innovation continues B. Braun's commitment to passive needlestick prevention. The catheter not only provides automatic protection against needlestick injuries but also includes a blood control mechanism that safeguards clinicians from blood exposure each time the hub is accessed. This feature significantly reduces the risk of exposure to bloodborne pathogens during the intravenous (IV) process.

Similarly, in December 2023, B. Braun unveiled its innovative CARESITE Micro Luer Access Device. This new product aims to enhance the safety of intravenous (IV) access for both patients and healthcare professionals by minimizing exposure to harmful chemicals and reducing the risk of infection.

Market Geographical Share

North America accounted for approximately 43.4% of the global central vascular access devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of chronic diseases, technological advancements, aging population, and expansion of healthcare facilities driving this market growth in this region.

Moreover, a major number of key player's presence, well-advanced healthcare infrastructure, and product launches would drive this market growth. For instance, in November 2023, BD introduced the SiteRite 9 Ultrasound System, designed to enhance clinician efficiency in placing various vascular access devices, including peripherally inserted central catheters (PICCs) and central venous catheters. This advanced system features a user-friendly 15.6-inch touchscreen and superior image quality, providing essential tools for successful catheter placement.

Also, in March 2022, Shockwave Medical, Inc. announced the global launch of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter following its receipt of both CE Mark and FDA clearance. This catheter, which has previously been available in a limited capacity, is specifically engineered to reduce treatment times for IVL procedures, offer alternative access options, and extend IVL therapy to patients with larger vessel sizes. The introduction of the Shockwave M5+ catheter represents a significant advancement in the treatment of severely calcified cardiovascular disease, enhancing the efficiency and effectiveness of vascular interventions.

In addition, key player's technological advancements and product approvals driving this market growth. For instance, in November 2023, BD unveiled its new PIVOTM Pro Needle-free Blood Collection Device. This innovative solution, which received 510(k) clearance from the FDA, is designed to work with integrated and long peripheral IV catheters, including BD's Nexiva Closed IV Catheter System with NearPort IV Access.

Market Segmentation

By Type

Peripheral Inserted Central Catheter

Non-tunneled Catheters

Tunneled Catheters

Implanted Ports

By Application

Drug Administration

Parenteral Nutrition

Chemotherapy

Blood Transfusion

Diagnostics & Testing

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgery Centers

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the central vascular access devices market include B. Braun SE, Terumo Medical Corporation, Teleflex Incorporated, Access Vascular, Inc., BD, Cook, Medtronic, Baxter, Smith's Group plc (ICU Medical, Inc.), and AngioDynamics.

Key Developments

In May 2023, Teleflex announced the launch of two new devices aimed at improving peripherally inserted central catheter (PICC) insertion procedures and minimizing complications. The newly introduced Arrow VPS Rhythm DLX device and the NaviCurve stylet are designed to work in tandem, providing vascular access specialists with a more efficient and predictable method for PICC placement.

In June 2021, medK introduced a needle-free solution for vascular access. This innovative connection allows for safe and rapid access to fluid lines while eliminating the risk of needle stick injuries. The new device enhances safety for both healthcare professionals and patients by removing the need for traditional needle-based access methods.

Why Purchase the Report?

To visualize the global central vascular access devices market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the central vascular access devices market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global central vascular access devices market report would provide approximately 62 tables, 56 figures, and 181 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Chronic Diseases & Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Risk of Infections & Complications
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Peripheral Inserted Central Catheter*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-tunneled Catheters
6.4. Tunneled Catheters
6.5. Implanted Ports

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Drug Administration *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Parenteral Nutrition
7.4. Chemotherapy
7.5. Blood Transfusion
7.6. Diagnostics & Testing

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgery Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. B. Braun SE *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Terumo Medical Corporation
11.3. Teleflex Incorporated
11.4. Access Vascular, Inc.
11.5. BD
11.6. Cook
11.7. Medtronic
11.8. Baxter
11.9. Smith's Group plc (ICU Medical, Inc.)
11.10. AngioDynamics (*LIST NOT EXHAUSTIVE)